Cargando…

Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland

Naloxone is an opioid antagonist that reverses the (respiratory-paralyzing) effects of opioids in the body within minutes. Naloxone can therefore reduce opioid overdose deaths. Take-home naloxone (THN) is an intervention recommended by the European Monitoring Centre for Drugs and Drug Addiction (EMC...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleißner, Simon, Stöver, Heino, Schäffer, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465660/
https://www.ncbi.nlm.nih.gov/pubmed/37233811
http://dx.doi.org/10.1007/s00103-023-03705-4
_version_ 1785098719774900224
author Fleißner, Simon
Stöver, Heino
Schäffer, Dirk
author_facet Fleißner, Simon
Stöver, Heino
Schäffer, Dirk
author_sort Fleißner, Simon
collection PubMed
description Naloxone is an opioid antagonist that reverses the (respiratory-paralyzing) effects of opioids in the body within minutes. Naloxone can therefore reduce opioid overdose deaths. Take-home naloxone (THN) is an intervention recommended by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the World Health Organization (WHO). It involves training opioid users and their relatives or friends in the use of naloxone and providing them with the drug in case of emergency. So far, THN has been implemented in Germany mainly by individual addiction support facilities. In order to fully exploit the potential of THN, it is necessary to establish the measure nationwide. In particular, THN can be included in the services offered in (low-threshold) addiction support facilities, in psychiatric facilities, in the context of opioid substitution treatment, and in the correctional system. This discussion article reviews the development of THN in Germany since 1998, highlights the difficulties and obstacles to its widespread implementation, and outlines how THN can succeed as an effective public health intervention in Germany. This is particularly relevant in view of the increasing number of drug-related deaths over the past 10 years.
format Online
Article
Text
id pubmed-10465660
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104656602023-08-31 Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland Fleißner, Simon Stöver, Heino Schäffer, Dirk Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz In der Diskussion Naloxone is an opioid antagonist that reverses the (respiratory-paralyzing) effects of opioids in the body within minutes. Naloxone can therefore reduce opioid overdose deaths. Take-home naloxone (THN) is an intervention recommended by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the World Health Organization (WHO). It involves training opioid users and their relatives or friends in the use of naloxone and providing them with the drug in case of emergency. So far, THN has been implemented in Germany mainly by individual addiction support facilities. In order to fully exploit the potential of THN, it is necessary to establish the measure nationwide. In particular, THN can be included in the services offered in (low-threshold) addiction support facilities, in psychiatric facilities, in the context of opioid substitution treatment, and in the correctional system. This discussion article reviews the development of THN in Germany since 1998, highlights the difficulties and obstacles to its widespread implementation, and outlines how THN can succeed as an effective public health intervention in Germany. This is particularly relevant in view of the increasing number of drug-related deaths over the past 10 years. Springer Berlin Heidelberg 2023-05-26 2023 /pmc/articles/PMC10465660/ /pubmed/37233811 http://dx.doi.org/10.1007/s00103-023-03705-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle In der Diskussion
Fleißner, Simon
Stöver, Heino
Schäffer, Dirk
Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland
title Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland
title_full Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland
title_fullStr Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland
title_full_unstemmed Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland
title_short Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland
title_sort take-home naloxon: ein baustein der drogennotfallprophylaxe auch in deutschland
topic In der Diskussion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465660/
https://www.ncbi.nlm.nih.gov/pubmed/37233811
http://dx.doi.org/10.1007/s00103-023-03705-4
work_keys_str_mv AT fleißnersimon takehomenaloxoneinbausteinderdrogennotfallprophylaxeauchindeutschland
AT stoverheino takehomenaloxoneinbausteinderdrogennotfallprophylaxeauchindeutschland
AT schafferdirk takehomenaloxoneinbausteinderdrogennotfallprophylaxeauchindeutschland